Progesterone and preterm birth [2]

American Journal of Obstetrics and Gynecology

Volumn 190, Issue 6, 2004, Pages 1798-1799

  Einstein, Francine H ^a   Bracero, Luis A ^a  

^a Dept Obstet Gynecol Women's H ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROGESTERONE;

DRUG EFFECT; DRUG EFFICACY; FREQUENCY ANALYSIS; GESTATION PERIOD; GESTATIONAL AGE; HORMONAL REGULATION; HORMONAL THERAPY; HUMAN; LETTER; PATIENT SELECTION; PREMATURE LABOR; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; STATISTICAL ANALYSIS; THIRD TRIMESTER PREGNANCY; UTERUS CONTRACTION;

ADMINISTRATION, INTRAVAGINAL; FEMALE; GESTATIONAL AGE; HUMANS; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY OUTCOME; PREVALENCE; PROGESTERONE; RANDOMIZED CONTROLLED TRIALS; REFERENCE VALUES; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 3442898791     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2003.12.045     Document Type: Letter

References (2)

1. da Fonseca E.B., Bittar E.R., Carvalho M.H.B., Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol. 188:2003;419-424
2. Meis P.J. National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network. 17α-Hydroxyprogesterone acetate to prevent recurrent preterm birth. Am J Obstet Gynecoi. 187:2002;S54